Navigation Links
New Light on Working of Brain Networks

A report in the Journal Cell (April 20 from the researchers from Yale School of Medicine and University of Crete School of Medicine has for the first time found evidence of a// molecular mechanism that dynamically alters the strength of higher brain network connections.

This discovery may help the development of drug therapies for the cognitive deficits of normal aging, and for cognitive changes in schizophrenia, bipolar disorder, or attention deficit hyperactivity disorder (ADHD).

“Our data reveal how the brain’s arousal systems influence the cognitive networks that subserve working memory—which plays a key role in abstract thinking, planning, and organizing, as well as suppressing attention to distracting stimuli,” said Amy Arnsten, lead author and neurobiology professor at Yale.

The brain’s prefrontal cortex (PFC) normally is responsible for so-called executive functions. The ability of the PFC to maintain such memory-based functions declines with normal aging, is weakened in people with ADHD, and is severely disrupted in disorders such as schizophrenia and bipolar disorder.

The current study found that brain cells in PFC contain ion channels called hyperpolarization-activated cyclic nucleotide-gated channels (HCN) that reside on dendritic spines, the tiny protrusions on neurons that are specialized for receiving information. These channels can open when they are exposed to cAMP (cyclic adenosine monophosphate). When open, the information can no longer flow into the cell, and thus the network is effectively disconnected. Arnsten said inhibiting cAMP closes the channels and allows the network to reconnect.

The study also found alpha-2A adrenergic receptors near the channels that inhibit the production of cAMP and allow the information to pass through into the cell, connecting the network. These receptors are stimulated by a natural brain chemical norepinephrine or by medications like guanfacine.


'"/>




Page: 1 2 3

Related medicine news :

1. Light therapy decreases depression during pregnancy
2. Light therapy devotes new hope in advanced lung cancer
3. Reducing TB With Ultraviolet Light
4. Exposure To Night Light may Increase The Risk Of Leukemia
5. Improving Lighting Could Bring About A Change In Alzheimers Patients
6. Light Cigarettes - Not So Light?
7. Fungal Infections Effectively Controlled By Light Therapy
8. Light can help fight gum bacteria
9. Lights can lighten your moods
10. Night Light Found To Increase The Risk Of Leukemia
11. UV- Light Tanning As A Type Of Substance-Related Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Light Working Brain Networks

(Date:10/10/2008)... MONTVALE, N.J., Oct. 10 /PRNewswire-FirstCall...ounces that it has appointed William,(Bill) Federi...oard to five,members., Mr. Federici joined West P... Financial Officer in August of 2003. Under his fi... have grown to more than $1.0 billion from,$300 mi...
(Date:10/10/2008)... RICHMOND, Va., Oct. 10 /PRNewswire/ -- Do you...ook? Can,t get around town? Attend the October,17 ...or the Blind and,Vision Impaired, and see how inst...red to lead productive, fulfilling lives through n...enter, located at 401 Azalea Avenue, is holding an...
(Date:10/10/2008)..., Upon the completion of ...BS Division of CDM Media proudly announces their n...or chief information technology executives in heal... Summit will launch May 10-12, 2009 at the Four Se... Honolulu, HI (PRWEB) October 11, 2008 -- ...
(Date:10/10/2008)..., DANVILLE, PA The American Nurses Credentialing...nter (GMC) as a Magnet hospital. The news came via...ses and staff who broke out with cheers and applau...ania hospitals and only 294 hospitals in the Unit...han 6,000 hospitals are eligible for this recognit...
Breaking Medicine News(10 mins):Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2Health News:Geisinger Medical Center earns prestigious Magnet designation 2
...gh fungus-fighter drug - Noxafil, //which gained F... protecting patients with crippled immune systems,... The results of their study were published in the...art from preventing fungal infections, Noxafil, kn...
... has called for an action plan and comprehensive s... at a National Workshop// on ‘Human - Leopard Conf...eena, said that we need to have a re-look at our e...an-animal conflict is one of the challenging issue...
...patients for publishing their views on hospitals a... performance of their GPs or hospitals through pat...helping others to decide where to go for treatment...id that the aim is to improve the performance of t...
..., the University of Chicago, and Stanford, have st...essure earlier and// being more aggressive, physic...nificantly better than their counterparts. Their...Jan. 22, 2007, issue of the Archives of Internal M...
Other Medicine News:Health News:Hypertension Treatment: US Beats Europe 2Health News:Hypertension Treatment: US Beats Europe 3
(Date:10/9/2008)...ht Day 2008 focuses on the need to protect the eye...re/ -- Of the 45 million people worldwide who,are ...ers of them could,have avoided their blindness if ...view the Multimedia News Release, go to:, http://w...orld,s leader in eye care products and equipment, ...
(Date:10/8/2008)...A, Va., Oct. 8 /PRNewswire-USNewswire/ -- The fact... die from HIV/AIDS in,sub-Saharan Africa. More tha...an Africa have already died of AIDS. The Foundatio... ensure the dying and their families,find compassi...HSSA,s,innovative partnering initiative links Afri...
(Date:10/8/2008)... University Food Scientists Expand Testing Using C... Assay, PORTLAND, Maine, Oct. 8 /- W...with the release of results from a new study,showi...monly consumed,fruits like apples, bananas, red gr...e Cellular Antioxidant Activity (CAA) assay. New r...
(Date:10/7/2008)..., Oct. 7 /- Prometheus Laboratories I...ounced findings from its,development of PROMETHEUS...for irritable bowel syndrome (IBS). The findings s... particular biomarkers in blood samples,between IB...e biomarkers,combined with a proprietary algorith...
Breaking Medicine Technology:ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Specialists in drug discovery and development convene 13455 1Specialists in drug discovery and development convene 13455 2Independence Blue Cross and The Childrens Hospital of Philadelphia Reach Seven Year Agreement 13453 1Independence Blue Cross and The Childrens Hospital of Philadelphia Reach Seven Year Agreement 13453 2Independence Blue Cross and The Childrens Hospital of Philadelphia Reach Seven Year Agreement 13453 3Achieving CVIS Goals Webinar 13451 1Achieving CVIS Goals Webinar 13451 2Autism Society of America Hosts Day on the Hill 13449 1Autism Society of America Hosts Day on the Hill 13449 2
...SYDNEY, Australia--(BUSINESS WIRE)--Jun 27, 2007 -...elltherapeutics.com) today,announced that it provi...a clinical trial to assess the safety, feasibility... stem cells into,spinal cord injury (SCI) patients... at the 13th,Annual Meeting of the International S...
...Final Results from Exploratory Phase IIa Clinical ...TO, June 28, 2007 /PRNewswire-FirstCall/ - Transit...nces the results from,its exploratory Phase IIa cl...tments with gastrin-based therapy, E1-I.N.T.(TM), ...ol parameters, including,haemoglobinA1C (HbA1c), f...
Other Medicine Technology:Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for,Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical,Study 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 3A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 4A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 5